Abstract
To describe the change in the epidemiology of health care–associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to 25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018. Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus methicillin, resistance increased from 31 to 41%.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aydin M, Ergonul O, Azap A et al (2018) Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections. J Hosp Infect 98:260–263
Isler B, Keske S, Aksoy M et al (2019) Antibiotic overconsumption and resistance in Turkey. Clin Microbiol Infect 25:651–653
Mitchell R, Taylor G, Rudnick W et al (2019) Trends in health care-associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys. CMAJ 191:E981–E9E8
Ergonul O, Aydin M, Azap A et al (2016) Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality. J Hosp Infect 94:381–385
CDC/NHSN Surveillance Definitions for Specific Types of Infections. Center for Disease Control and Prevention (CDC) 2017
CLSI (2016) Subcommittee on Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute
Dogan O, Yesilkaya A, Menekse S et al (2020) Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: a multicentre observational study by the Turkish Fungal Infections Study Group. Int J Antimicrob Agents 56(1):105992. https://doi.org/10.1016/j.ijantimicag.2020.105992
Bassetti M, Giacobbe DR, Vena A et al (2019) Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care 23:219
Jean SS, Chang YC, Lin WC, Lee WS, Hsueh PR, Hsu CW (2020) Epidemiology, treatment, and prevention of nosocomial bacterial pneumonia. J Clin Med 9
Ewig S, Kolditz M, Pletz MW, Chalmers J (2019) Healthcare-associated pneumonia: is there any reason to continue to utilize this label in 2019? Clin Microbiol Infect 25:1173–1179
Bakthavatchalam YD, Veeraraghavan B (2017) Challenges, issues and warnings from CLSI and EUCAST Working Group on polymyxin susceptibility testing. J Clin Diagn Res 11:DL03–DDL4
Girardello R, Cury AP, Franco MRG et al (2018) Colistin susceptibility testing and Vitek-2: is it really useless? Diagn Microbiol Infect Dis 91:309–311
EARS (2019) Surveillance of antimicrobial resistance in Europe 2018. In: Stockholm: European Centre for Disease Prevention and Control (ECDC)
Balkhy HH, El-Saed A, Alshamrani MM et al (2020) Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016. Antimicrob Resist Infect Control 9:21
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Aydın, M., Azak, E., Bilgin, H. et al. Changes in antimicrobial resistance and outcomes of health care–associated infections. Eur J Clin Microbiol Infect Dis 40, 1737–1742 (2021). https://doi.org/10.1007/s10096-020-04140-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-020-04140-y